Results 201 to 210 of about 39,176 (275)

Unexpected resolution of clozapine-induced obsessive-compulsive symptoms with cariprazine augmentation: a case report. [PDF]

BMC Psychiatry
Rammouz I, El Oumary O, Hamri S, Akebour K, Mouhadi K, Doufik J, Boujraf S.   +6 more
europepmc   +1 more source

Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case Report. [PDF]

Case Rep Psychiatry
Alam R, Cotes RO, Goldsmith DR.
europepmc   +1 more source

Treating Unmet Needs in Psychiatry (TUNE-UP): targeted service increases out-patient initiations of clozapine. [PDF]

BJPsych Open
Ahmad Khan Z, Varvari I, Mancini V, Zita-Zauchenberger C, Kantor S, Fanshawe JB, Musiiwa S, Pledge A, Pearce B, de La Motte de Broöns de Vauvert SJGN, Quested D, Maughan D, Baskerville-Butler J, McGuire P, Howes OD, Pillinger T, McCutcheon RA.   +16 more
europepmc   +1 more source

Clozapine treatment in the early stages of schizophrenia. [PDF]

Curr Opin Psychiatry
Davani AJ, Gallego JA, Malhotra AK.
europepmc   +1 more source

Global trends in clozapine utilisation between 2014 and 2024: a longitudinal epidemiological study with data from 75 countries. [PDF]

Lancet Reg Health Eur
Fitzgerald I, O'Dwyer S, Dhubhlaing CN, Gee S, Sahm LJ, Wheeler A, Hurley E, Saastamoinen L, Waksmundzka-Walczuk A, Donohue G, Shiers D, Gupta V, Howe J, Correll CU, Højlund M.   +14 more
europepmc   +1 more source

Longitudinal trends in blood concentrations of clozapine and norclozapine, inflammatory markers, and clinical outcomes in Japanese patients: a 12-week prospective study. [PDF]

Front Psychiatry
Nakamura M, Nagamine T, Yokoe H, Shimomura Y.   +3 more
europepmc   +1 more source

Adjuvant Mood Stabilisers for Long-Term Management of Treatment-Resistant Schizophrenia: A Case Report. [PDF]

Cureus
Anyameluhor F, Elliott C.
europepmc   +1 more source

Assessing demographic and clinical characteristics and healthcare resource utilization of patients with schizophrenia with inadequate response to antipsychotic treatment. [PDF]

BMC Psychiatry
Hejazi A, Bron M, Perez-Rodriguez MM, Attar A, Burgess MV, Giraldo E, Nimer J, Biskupiak J.   +7 more
europepmc   +1 more source

Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS). [PDF]

Alpha Psychiatry
Zhao X, Cheng Y, He S, Mou F, Li W, Yu S.   +5 more
europepmc   +1 more source